Anti-malaria vaccine uses attenuated malaria parasites

07/2/2013 | Yahoo

Researchers have developed an anti-malaria vaccine that uses blood-stage malaria parasites that were modified with a chemical agent to prevent replication. Mice injected with the vaccine showed immunity to a variety of malaria species for more than 100 days, according to the study published in the Journal of Clinical Investigation.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY